Latest Litigation News

Inghams Group Limited (ASX:ING) returned to poultry volume growth in FY26, but rising costs, a tax dispute and weaker earnings sharply reduced shareholder returns. The company enters FY27 with lower net debt, elevated leverage and a value-led turnaround strategy still to prove itself.

Yowie Group’s FY26 loss narrowed sharply after cost reductions and a non-cash loan impairment reversal, but revenue fell 27% and operating cash flow turned deeply negative. The confectionery maker remains loss-making, has negative net assets and faces uncertainty over funding, supply and the return of its ASX quotation.

Ovanti has reported a A$23.61 million FY2026 loss, A$21.27 million in operating cash outflows and only A$291,867 in cash at year end. The ASX-listed fintech has abandoned BNPL globally, but says its continuing operations and proposed funding initiatives provide a basis to keep trading despite a material going-concern uncertainty.

Nuix has returned to statutory profit and generated substantially more cash in FY26, while its Nuix Neo platform became the main engine of growth. The annual report also flags a planned $5 million restructuring, an undisclosed insurance provision and unresolved litigation risks.

Amara Minerals has warned of a material uncertainty over its ability to continue as a going concern after reporting an $8.79 million FY2026 loss and $2.08 million in cash. The company is advancing Victorian gold-antimony exploration, but further equity funding is required and a GST-related court dispute remains unresolved.

Benjamin Hornigold Limited (ASX:BHD) delivered a 9.93% portfolio return in FY2026 but still posted a $420,931 loss after $565,697 in legal fees. Two settlements worth $2.6 million were received after year-end, while an $8.97 million judgment against JB Markets was assigned no value.

Mayne Pharma has settled patent litigation with Sun Pharma over IMVEXXY, establishing 21 October 2032 as the agreed potential generic entry date, subject to court approval. The settlement involves no upfront payment, while one further Paragraph IV dispute remains unresolved.

Identitii’s BNDRY platform gained customers and recurring revenue in FY26, but the company ended the year with just $107,483 in cash, negative net assets and a material uncertainty over its ability to continue as a going concern. A subsequent convertible note facility provides a committed $5 million, while access to a further $15 million remains conditional.

Eminence Minerals has cut its FY2026 loss and raised its pro forma cash position to about A$5.4 million after selling the Mata da Corda titanium project. The portfolio is now centred on Hamersley iron ore and Brazilian rare earth exploration, but heritage litigation, ungranted tenure and future funding needs remain material constraints.

Brazilian Critical Minerals has reported striking economics for its Ema rare earths project, including a US$1.47 billion post-tax NPV, 105% IRR and six-month payback. The company’s A$7.87 million FY2026 loss, December debt maturity, permitting requirements and unresolved Drake dispute leave the development case dependent on execution and further funding.

US1 Critical Minerals has warned of a material uncertainty over its ability to continue as a going concern, with only $302,641 in cash at year-end. Its forecast depends heavily on completing a conditional sale of Tanzanian uranium licences for an initial US$1 million.

Netwealth says two subsidiaries have been served with a class action linked to First Guardian investment options offered through its superannuation master fund. The claim follows a $101 million compensation program completed in January, but the announcement does not disclose the new action’s potential cost.